2026-02-05 21:33 UTC
@violetblue@mastodon.social
Cool! I saved this a few years ago.
Phase 3 research study: Metformin reduces SARS-CoV-2 in a Phase 3 Randomized Placebo Controlled Clinical Trial
https://www.medrxiv.org/content/10.1101/2023.06.06.23290989v1
“In the COVID-OUT phase 3, randomized, placebo-controlled trial of outpatient treatment of COVID-19, metformin had a 42% reduction in ER visits/hospitalizations/death through 14 days; a 58% reduction in hospitalizations/death through 28 days, and a 42% reduction in Long COVID through 10 months”
Replies (0)
No replies.